Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Damian Kołakowski
Observed name:
Damian Kolakowski
Institution:
Celon Pharma (Poland)
Observed institutions:
Celon Pharma (Poland),
Institute of Biochemistry and Biophysics, Polish Academy of Sciences,
Polish Academy of Sciences
ORCID:
0000-0002-4394-6811
Observed ORCID:
0000-0002-4394-6811
OpenAlex ID:
A5080283995
Yeast-model-based study identified myosin- and calcium-dependent calmodulin signalling as a potential target for drug intervention in chorea-acanthocytosis
2019
·
Piotr Soczewka
, Damian Kolakowski
, et al.
·
Disease Models & Mechanisms
·
24
PDF
The GTPase Arf1 Is a Determinant of Yeast Vps13 Localization to the Golgi Apparatus
2021
·
Damian Kolakowski
, Weronika Rzepnikowska
, et al.
·
International Journal of Molecular Sciences
·
22
PDF
The binding of the APT1 domains to phosphoinositides is regulated by metal ions in vitro
2020
·
Damian Kolakowski
, Joanna Kaminska
, et al.
·
Biochimica et Biophysica Acta (BBA) - Biomembranes
·
21
PDF
Mutations in GDAP1 Influence Structure and Function of the Trans-Golgi Network
2021
·
Katarzyna Binięda
, Weronika Rzepnikowska
, et al.
·
International Journal of Molecular Sciences
·
18
PDF
Inhibition of Dephosphorylation of Dolichyl Diphosphate Alters the Synthesis of Dolichol and Hinders Protein N-Glycosylation and Morphological Transitions in Candida albicans
2019
·
Anna Janik
, Monika Niewiadomska
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Białka z rodziny Vps13 – od funkcji molekularnej do patogenezy chorób neurodegeneracyjnych
2018
·
Joanna Kamińska
, Damian Kolakowski
·
Postępy Biochemii
·
4
PDF
Abstract 3184: Development of an innovative bifunctional CPL976-MMAE conjugate based on a bispecific anti-PD-L1/ant-AXL antibody with a dual mechanism of action
2024
·
Krysztof Lacek
, Anna Jablonska
, et al.
·
Cancer Research
·
1
Abstract 3080: Site-specific conjugation of CPL976H-MMAE enables stable and selective dual targeting of PD-L1 and AXL
2026
·
Delfina Popiel
, Filip Mitula
, et al.
·
Cancer Research
Development of Bispecific Antibody Targeting Human IL-17A and IL-6
2026
·
Beata Pamuła
, Martyna Banach
, et al.
·
Antibodies
PDF
Abstract 3105: Unveiling the potential of humanized bispecific antibody: a novel approach to tumor suppression in oncology
2025
·
Anna Jablonska
, Damian Kolakowski
, et al.
·
Cancer Research
Abstract 5084: A first-in-class bispecific antibody CPL976 with a dual PD-L1/AXL mechanism of action that promotes common biological antitumor effects in in vitro and in vivo models
2024
·
Delfina Popiel
, Damian Kołakowski
, et al.
·
Cancer Research
Abstract B121: CPL976, an innovative bispecific antibody targeting AXL and PD-L1 axis as a potential new anticancer therapeutic
2023
·
Agnieszka Bojko-Matuszek
, Damian Kołakowski
, et al.
·
Molecular Cancer Therapeutics
Abstract B146: Design and preclinical evaluation of CPL976-MMAE - novel, potent AXL-PD-L1 bispecific antibody conjugated with MMAE in targeted anticancer therapy
2023
·
Delfina Popiel
, Krzysztof Lacek
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
13
Citation count:
101
H-index:
5
I10-index:
5
Year
Topic
Type
